Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
NCT04990921
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
COMBINATION_PRODUCT:
Palliative Radiation and Pembrolizumab
Sponsor
University of Louisville
Collaborators
[object Object]